Preclinical analytical and manufacturing platforms to help our clients bridge their ATMP development to the clinic with well-established CRO service workflows and product types.
uBriGene offers extensive CRO services for cell and gene therapy developers, including tech transfer, process and analytical development, and scale-up. Our platform services help clients reduce timelines and costs compared to starting process development from scratch.
Robust plasmid manufacturing platform with extensive experience producing preclinical plasmids to support phase appropriate manufacturing of viral vectors and mRNA drug products.
View Plasmid Development and Production ServicesProcess development, scale-up, and preclinical vector production experience across key viral vector platforms including lentivirus, AAV, and adenovirus.
View Viral Vector Development and Production ServicesExplore our innovative and robust vitro transcription sgRNA production platform, offering cost effectiveness and gene editing efficiency.
Breakthrough RNA-LNP production platform delivers high quality, and potent RNA therapeutics, including mRNA, circRNA, and saRNA.
Centers of Excellence for manufacturing and testing
GMP batches successfully delivered
INDs filed and accepted with FDA, EMA, and CDE
Centers of Excellence for manufacturing and testing
GMP batches successfully delivered
INDs filed and accepted with FDA, EMA, and CDE
Discover the current manufacturing approaches for LVV and its deployment in cell therapies.
Learn more about our CAR-T CDMO manufacturing for high-quality therapies.
Discover our mRNA-LNP manufacturing capabilities & LNP microfluidic technology platform
Learn how to accelerate the development of iPSC-derived cell therapies.
